Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
John E Dick
Affiliation
Princess Margaret Cancer Centre, University Health Network
ORCID
Career Start Year
1980
Papers
238
H Index
94
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36763002
In Vivo Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target.
Blood Cancer Discov
2023
37479893
Single-cell chromatin accessibility profiling of acute myeloid leukemia reveals heterogeneous lineage composition upon therapy-resistance.
Commun Biol
2023
37191437
Distinct Assemblies of Heterodimeric Cytokine Receptors Govern Stemness Programs in Leukemia.
Cancer Discov
2023
37021547
Simultaneous inhibition of Sirtuin 3 and cholesterol homeostasis targets acute myeloid leukemia stem cells by perturbing fatty acid β-oxidation and inducing lipotoxicity.
Haematologica
2023
37337105
Transcriptomic classes of BCR-ABL1 lymphoblastic leukemia.
Nat Genet
2023
37034724
Transcriptional Activation of Regenerative Hematopoiesis via Vascular Niche Sensing.
bioRxiv
2023
36720973
KDM6 demethylases integrate DNA repair gene regulation and loss of KDM6A sensitizes human acute myeloid leukemia to PARP and BCL2 inhibition.
Leukemia
2023
35019858
Multiomic Profiling of Central Nervous System Leukemia Identifies mRNA Translation as a Therapeutic Target.
Blood Cancer Discov
2022
35729851
Clonal haematopoiesis is associated with higher mortality in patients with cardiogenic shock.
Eur J Heart Fail
2022
35668135
The metabolic enzyme hexokinase 2 localizes to the nucleus in AML and normal haematopoietic stem and progenitor cells to maintain stemness.
Nat Cell Biol
2022
35639948
PLAG1 dampens protein synthesis to promote human hematopoietic stem cell self-renewal.
Blood
2022
35618837
A cellular hierarchy framework for understanding heterogeneity and predicting drug response in acute myeloid leukemia.
Nat Med
2022
35971894
Identification and characterization of inâ¿¿vitro expanded hematopoietic stem cells.
EMBO Rep
2022
35971851
Clonal hematopoiesis confers an increased mortality risk in orthotopic heart transplant recipients.
Am J Transplant
2022
36131042
A primary hierarchically organized patient-derived model enables in depth interrogation of stemness driven by the coding and non-coding genome.
Leukemia
2022
36087071
Clinical significance of clonal hematopoiesis in the setting of autologous stem cell transplantation for lymphoma.
Am J Hematol
2022
35156021
An improved molecular inversion probe based targeted sequencing approach for low variant allele frequency.
NAR Genom Bioinform
2022
35247876
Reconstructing Complex Cancer Evolutionary Histories from Multiple Bulk DNA Samples Using Pairtree.
Blood Cancer Discov
2022
35150236
SmMIP-tools: a computational toolset for processing and analysis of single-molecule molecular inversion probes-derived data.
Bioinformatics
2022
35142149
A novel CD34-specific T-cell engager efficiently depletes acute myeloid leukemia and leukemic stem cells <i>in vitro</i> and <i>in vivo</i>.
Haematologica
2022
34872104
A clinical laboratory-developed LSC17 stemness score assay for rapid risk assessment of patients with acute myeloid leukemia.
Blood Adv
2022
35263585
Identification of the global miR-130a targetome reveals a role for TBL1XR1 in hematopoietic stem cell self-renewal and t(8;21) AML.
Cell Rep
2022
33242413
The Transition from Quiescent to Activated States in Human Hematopoietic Stem Cells Is Governed by Dynamic 3D Genome Reorganization.
Cell Stem Cell
2021
33594052
Biological and therapeutic implications of a unique subtype of NPM1 mutated AML.
Nat Commun
2021
34389724
Interacting evolutionary pressures drive mutation dynamics and health outcomes in aging blood.
Nat Commun
2021
34103329
Enhancer Hijacking Drives Oncogenic <i>BCL11B</i> Expression in Lineage-Ambiguous Stem Cell Leukemia.
Cancer Discov
2021
34099695
Quantitative single-cell proteomics as a tool to characterize cellular hierarchies.
Nat Commun
2021
34244384
Mapping the cellular origin and early evolution of leukemia in Down syndrome.
Science
2021
34293334
Nicotinamide phosphoribosyltransferase inhibitors selectively induce apoptosis of AML stem cells by disrupting lipid homeostasis.
Cell Stem Cell
2021
33958784
A latent subset of human hematopoietic stem cells resists regenerative stress to preserve stemness.
Nat Immunol
2021
34343492
TFEB-mediated endolysosomal activity controls human hematopoietic stem cell fate.
Cell Stem Cell
2021
34228982
Human, mouse, and dog bone marrow show similar mesenchymal stromal cells within a distinctive microenvironment.
Exp Hematol
2021
33197925
CC-90009, a novel cereblon E3 ligase modulator, targets acute myeloid leukemia blasts and leukemia stem cells.
Blood
2021
33458693
Sphingosine-1-phosphate receptor 3 potentiates inflammatory programs in normal and leukemia stem cells to promote differentiation.
Blood Cancer Discov
2021
32649902
Human Aging Alters the Spatial Organization between CD34+ Hematopoietic Cells and Adipocytes in Bone Marrow.
Stem Cell Reports
2020
32086311
Relapse-Fated Latent Diagnosis Subclones in Acute B Lineage Leukemia Are Drug Tolerant and Possess Distinct Metabolic Programs.
Cancer Discov
2020
31990679
Cellular and molecular architecture of hematopoietic stem cells and progenitors in genetic models of bone marrow failure.
JCI Insight
2020
33298453
Integration of intra-sample contextual error modeling for improved detection of somatic mutations from deep sequencing.
Sci Adv
2020
33147339
CD200 expression marks leukemia stem cells in human AML.
Blood Adv
2020
32793890
Mutational landscape and patterns of clonal evolution in relapsed pediatric acute lymphoblastic leukemia.
Blood Cancer Discov
2020
30352278
Characterization of inv(3) cell line OCI-AML-20 with stroma-dependent CD34 expression.
Exp Hematol
2019
30089916
The stem cell-associated gene expression signature allows risk stratification in pediatric acute myeloid leukemia.
Leukemia
2019
31175119
An <i>ERG</i> Enhancer-Based Reporter Identifies Leukemia Cells with Elevated Leukemogenic Potential Driven by ERG-USP9X Feed-Forward Regulation.
Cancer Res
2019
31631013
Sphingolipid Modulation Activates Proteostasis Programs to Govern Human Hematopoietic Stem Cell Self-Renewal.
Cell Stem Cell
2019
31628330
Functional profiling of single CRISPR/Cas9-edited human long-term hematopoietic stem cells.
Nat Commun
2019
31127310
High efficiency error suppression for accurate detection of low-frequency variants.
Nucleic Acids Res
2019
30705411
A novel method for detecting the cellular stemness state in normal and leukemic human hematopoietic cells can predict disease outcome and drug sensitivity.
Leukemia
2019
30796022
A stemness screen reveals <i>C3orf54/INKA1</i> as a promoter of human leukemia stem cell latency.
Blood
2019
29342133
A Myc enhancer cluster regulates normal and leukaemic haematopoietic stem cell hierarchies.
Nature
2018
29988082
Prediction of acute myeloid leukaemia risk in healthy individuals.
Nature
2018
1 - 50 of 238
Column Actions
Search
Recommended Authors
Vadym Zaberezhnyy
University of Colorado Anschutz Medical Campus
Career Start Year
2009
Number of shared co-authors
3
Christopher Y Park
NYU Robert I. Grossman School of Medicine
Career Start Year
2006
Number of shared co-authors
3
Bastien Gerby
Universite de Toulouse, Inserm, Universite Toulouse III-Paul Sabatier
Career Start Year
2005
Number of shared co-authors
3
Fumio Nakahara
Graduate School of Medicine, The University of Tokyo
Career Start Year
2004
Number of shared co-authors
0
Christopher R Cogle
College of Medicine, University of Florida
Career Start Year
2003
Number of shared co-authors
3
Robert S Welner
University of Alabama at Birmingham
Career Start Year
2002
Number of shared co-authors
2
Jalila Chagraoui
Institute for Research in Immunology and Cancer, University of Montreal
Career Start Year
2000
Number of shared co-authors
2
Peter Kurre
Children's Hospital of Philadelphia
Career Start Year
1999
Number of shared co-authors
6
Maura Gasparetto
University of Colorado School of Medicine
Career Start Year
1998
Number of shared co-authors
3
Ravindra Majeti
Stanford University School of Medicine
Career Start Year
1998
Number of shared co-authors
6
Stephanie Halene
Smilow Cancer Center, Yale University School of Medicine
Career Start Year
1997
Number of shared co-authors
7
Christian Beaus??jour
CHU Sainte-Justine Research Center
Career Start Year
1996
Number of shared co-authors
3
Jichun Chen
and Blood Institute, National Institutes of Health
Career Start Year
1996
Number of shared co-authors
0
Timothy A Graubert
Massachusetts General Hospital
Career Start Year
1993
Number of shared co-authors
16
Yukio Nakamura
RIKEN BioResource Research Center
Career Start Year
1992
Number of shared co-authors
1
Michael W Becker
James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester
Career Start Year
1992
Number of shared co-authors
6
Carl Anthony Blau
Center for Cancer Innovation, University of Washington
Career Start Year
1991
Number of shared co-authors
3
Jose A Cancelas
Cincinnati Children's Hospital Medical Center
Career Start Year
1990
Number of shared co-authors
1
Peter Westervelt
Washington University School of Medicine
Career Start Year
1990
Number of shared co-authors
11
Volker Eckstein
Heidelberg University
Career Start Year
1990
Number of shared co-authors
2
Christof von Kalle
Berlin Institute of Health at Charite-Universitatsmedizin Berlin
Career Start Year
1990
Number of shared co-authors
13
Linzhao Cheng
Johns Hopkins University School of Medicine
Career Start Year
1989
Number of shared co-authors
2
William Matsui
Livestrong Cancer Institutes, Dell Medical School, University of Texas at Austin
Career Start Year
1989
Number of shared co-authors
4
Jana Krosl
The Leucegene Project at Institute for Research in Immunology and Cancer.
Career Start Year
1989
Number of shared co-authors
3
Guy Sauvageau
Universite de Montreal
Career Start Year
1988
Number of shared co-authors
7
Clayton A Smith
University of Colorado, Aurora CO.
Career Start Year
1987
Number of shared co-authors
7
Richard J Jones
Sidney Kimmel Cancer Center, Johns Hopkins University
Career Start Year
1986
Number of shared co-authors
4
Denis-Claude Roy
Universite de Montreal
Career Start Year
1985
Number of shared co-authors
2
George Q Daley
Boston Children's Hospital, Harvard Medical School
Career Start Year
1982
Number of shared co-authors
14
John F DiPersio
Washington University School of Medicine
Career Start Year
1978
Number of shared co-authors
14
row(s) 1 - 30 of 30
Collaborators
Faiyaz Notta
2Ontario Institute for Cancer Research
Co-authored papers
17
Gary D Bader
University of Toronto
Co-authored papers
16
Alex Murison
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
15
Kolja Eppert
McGill University
Co-authored papers
13
Michelle Chan-Seng-Yue
Princess Margaret Cancer Centre
Co-authored papers
13
Sergei Doulatov
University of Washington
Co-authored papers
13
Sasan Zandi
University of Toronto
Co-authored papers
13
Charles G Mullighan
St Jude Children's Research Hospital
Co-authored papers
11
John D McPherson
Ontario Institute for Cancer Research
Co-authored papers
10
Suzanne Kamel-Reid
Toronto General Hospital, University Health Network, University of Toronto
Co-authored papers
9
Peter W Zandstra
Co-authored papers
8
Mathieu Lupien
Princess Margaret Cancer Research Centre
Co-authored papers
8
Aaron D Schimmer
Princess Margaret Cancer Centre
Co-authored papers
8
Steven Gallinger
Lunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto
Co-authored papers
7
Jinghui Zhang
Changhai Hospital, Second Military Medical University
Co-authored papers
6
Rose Hurren
Princess Margaret Cancer Centre
Co-authored papers
6
Michael Rusch
St Jude Children's Research Hospital
Co-authored papers
6
Kathryn G Roberts
St Jude Children's Research Hospital
Co-authored papers
6
Luigi Naldini
Vita-Salute San Raffaele University
Co-authored papers
6
Marcela Gronda
Princess Margaret Cancer Centre
Co-authored papers
5
Thomas J Hudson
Ontario Institute for Cancer Research
Co-authored papers
5
Steven M Kornblau
The University of Texas MD Anderson Cancer Center
Co-authored papers
5
John Easton
St Jude Children's Research Hospital
Co-authored papers
5
Lincoln Stein
Ontario Institute for Cancer Research, University Avenue
Co-authored papers
5
Brian Raught
Princess Margaret Cancer Centre, University Health Network
Co-authored papers
4
Andrew M K Brown
Ontario Institute for Cancer Research
Co-authored papers
4
Lawrence E Heisler
Ontario Institute for Cancer Research
Co-authored papers
4
Jeffrey L Wrana
Lunenfeld-Tanenbaum Research Institute Mount Sinai Hospital
Co-authored papers
4
Leonard D Shultz
The Jackson Laboratory Cancer Center
Co-authored papers
4
Mignon L Loh
University of Washington
Co-authored papers
4
1 - 30